Cheil Bio Co

Cheil Bio Co Net Margin

Delisted·Feb 25, 2026

The Net Profit Margin of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -3.00 %. In the previous year, Net Profit Margin was -11.94 % — a change of -74.91% (higher).

Net Margin

-3.00 %

YoY

-74.91%

Last updated:

Net Profit Margin of Cheil Bio Co is 2024 -3.00 % . Net Profit Margin of Cheil Bio Co was 2023 -11.94 % . It decreases by -74.91% higher compared to the previous year.

For Cheil Bio Co, the net margin of -3.0% is down versus 5.2% a few years ago.

The Cheil Bio Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2017
2.82 KRW
Jan 1, 2018
3.74 KRW
Jan 1, 2019
8.89 KRW
Jan 1, 2020
5.23 KRW
Jan 1, 2021
-4.21 KRW
Jan 1, 2022
-11.13 KRW
Jan 1, 2023
-11.94 KRW
Jan 1, 2024
-3.00 KRW
The Cheil Bio Co Net Margin history
YEARNet MarginYoY
-3.00 %-74.91%
-11.94 %+7.29%
-11.13 %+164.16%
-4.21 %-180.53%
5.23 %-41.14%
8.89 %+137.61%
3.74 %+32.64%
2.82 %-0.37%
2.83 %+16.25%
2.43 %+0.71%
2.42 %+25,737.33%
0.01 %-66.38%
0.03 %+18.13%
0.02 %-27.73%
0.03 %-20.65%
0.04 %-147.78%
-0.09 %+129.98%
-0.04 %-236.85%
0.03 %+323.56%
0.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Net Profit Margin of Cheil Bio Co is -3.00 % in 2024.

Net Profit Margin of Cheil Bio Co changed from -11.94 % to -3.00 %, representing a -74.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cheil Bio Co

All Key Metrics — Cheil Bio Co